Shearson

NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)

Retrieved on: 
Tuesday, January 23, 2024

“The NAYA leadership team brings an agile entrepreneurial platform, broad development and commercialization experience, and access to public capital, which will unlock the potential of our promising AAV gene therapy platform for mitochondrial genetic diseases.

Key Points: 
  • “The NAYA leadership team brings an agile entrepreneurial platform, broad development and commercialization experience, and access to public capital, which will unlock the potential of our promising AAV gene therapy platform for mitochondrial genetic diseases.
  • The program has received over $6 million in grant funding to date and qualifies for Regenerative Medicine Advanced Therapy (RMAT) designation and multiple priority FDA review vouchers.
  • The combination of multiple orphan indications, multiple routes of administration, and multiple AAV serotypes applicable supports a broad gene therapy platform for mitochondrial orphan diseases.
  • The Florida Biotechnologies Transaction is contingent on the closing of the INVO Merger and sufficient financing to further develop the gene therapy programs from Florida Biotechnologies.

NAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Merger

Retrieved on: 
Friday, November 10, 2023

"I am delighted to join NAYA Biosciences upon the closing of its public merger," commented Dr. Peter Kash.

Key Points: 
  • "I am delighted to join NAYA Biosciences upon the closing of its public merger," commented Dr. Peter Kash.
  • "We welcome Peter to NAYA's board as we close our public merger with INVO and prepare to execute an ambitious growth strategy," added Dr. Daniel Teper, Chairman and CEO of NAYA Biosciences.
  • He is currently the cofounder and Vice Chairman of TargImmune Therapeutics (Switzerland) and cofounder and Managing Director of Camelot BioCapital.
  • Dr. Kash completed post graduate classes on Making Boards of Directors More Effective at Harvard Business School.

Don Clark Appointed CEO of Cerebelly, The First and Only-Science Backed Cognitive Development-Focused Baby Food Brand

Retrieved on: 
Tuesday, August 8, 2023

DENVER, Aug. 8, 2023 /PRNewswire/ -- Cerebelly, the first and only science-backed and patented, cognitive development-focused baby food brand, announced today that Don Clark will join the brand as Chief Executive Officer, effective immediately.

Key Points: 
  • DENVER, Aug. 8, 2023 /PRNewswire/ -- Cerebelly, the first and only science-backed and patented, cognitive development-focused baby food brand, announced today that Don Clark will join the brand as Chief Executive Officer, effective immediately.
  • Clark brings 30 years of senior experience in retail and merchandising expertise in various categories including extensive work at progressive industry leaders like Target, Whole Foods Market, and Giant Eagle.
  • Don Clark Appointed CEO of Cerebelly, The First and Only-Science Backed Cognitive Development-Focused Baby Food Brand
    Following the recent Series A Closure, Greg Shearson, who has been at helm of the CEO position since 2020, is taking a step back from the day-to-day role to return to a position as an investor and board member.
  • "Cerebelly's mission and incredible growth over the last three years is a testimony to the strength of the brand as an industry leader," said Clark.

LetsGetChecked Announces Appointment of New Board Member

Retrieved on: 
Thursday, March 9, 2023

LetsGetChecked, a global healthcare solutions company, announced today the appointment of Robin Leopold, Executive Vice President and Head of Human Resources at JPMorgan Chase, and a member of the company’s Operating Committee, to its Board of Directors.

Key Points: 
  • LetsGetChecked, a global healthcare solutions company, announced today the appointment of Robin Leopold, Executive Vice President and Head of Human Resources at JPMorgan Chase, and a member of the company’s Operating Committee, to its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20230309005039/en/
    Robin Leopold, EVP and Head of Human Resources at JPMorgan Chase (Photo: Business Wire)
    “I am pleased to welcome Robin Leopold to LetsGetChecked’s Board of Directors,” said Peter Foley, Founder and CEO at LetsGetChecked.
  • Leopold also spent more than 20 years at Citi and its predecessor companies, starting at Shearson Lehman Hutton.
  • To learn more about LetsGetChecked, please visit www.LetsGetChecked.com .

Senior Vice President and Head of Human Resources Joanne Rodgers Appointed to New York Life’s Executive Management Committee

Retrieved on: 
Tuesday, February 21, 2023

New York Life, America’s largest mutual life insurer1, today announced the appointment of Joanne Rodgers, Senior Vice President and Head of Human Resources, to the company’s Executive Management Committee.

Key Points: 
  • New York Life, America’s largest mutual life insurer1, today announced the appointment of Joanne Rodgers, Senior Vice President and Head of Human Resources, to the company’s Executive Management Committee.
  • Ms. Rodgers will continue to report to Sheila Davidson, Executive Vice President and Chief Legal & Administrative Officer.
  • Ms. Rodgers currently oversees New York Life’s Human Resources capabilities and organization.
  • Prior to joining New York Life, Ms. Rodgers served at the National Association of Securities Dealers, now FINRA, and Shearson Lehman Brothers.

COUR Pharmaceuticals Announces Biotechnology Industry Veteran Robert F. Carey Joins Board of Directors as Lead Independent Director

Retrieved on: 
Wednesday, February 8, 2023

CHICAGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system, today announced the appointment of Robert F. Carey to its board of directors, effective immediately.

Key Points: 
  • CHICAGO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- COUR Pharmaceuticals, a clinical-stage biotechnology company developing novel immune-modifying nanoparticles designed to reprogram the immune system, today announced the appointment of Robert F. Carey to its board of directors, effective immediately.
  • Mr. Carey will serve as COUR’s Lead Independent Director.
  • “We are extremely pleased to welcome Bob Carey to COUR’s board,” said John J. Puisis, Founder & CEO of COUR.
  • I look forward to working closely with John and the COUR team in positioning COUR for tremendous growth and success in the coming years.”

Milestone Scientific Appoints Fund Manager and Finance Veteran Neal Goldman as Chairman of the Board of Directors

Retrieved on: 
Thursday, January 5, 2023

Mr. Goldman has served on the Company’s board since 2019 and succeeds Leslie Bernhard, who has resigned following years of dedicated service.

Key Points: 
  • Mr. Goldman has served on the Company’s board since 2019 and succeeds Leslie Bernhard, who has resigned following years of dedicated service.
  • Mr. Goldman is the President and Founder of Goldman Capital Management, Inc., a family office since 2018, which was previously an investment advisory firm founded in 1985.
  • Mr. Goldman serves as Chairman of Charles & Colvard, Ltd. since 2016 and served on the board of Imageware Systems, Inc. until November 2020.
  • He brings an impressive track record as a fund manager and value investor, with more than 35 years of capital markets experience.

LVW Advisors CEO Named CEO of the Year for 2022 by RIA Intel

Retrieved on: 
Thursday, September 15, 2022

ROCHESTER, N.Y., Sept. 15, 2022 /PRNewswire/ -- LVW Advisors, a Rochester-based independent financial advisory firm, is thrilled to announce that CEO and Founder Lori Van Dusen has been named CEO of the Year for 2022 by RIA Intel, part of Institutional Investor, a leading international business-to-business publication. This year's awards are the first of their kind from RIA Intel. 

Key Points: 
  • ROCHESTER, N.Y., Sept. 15, 2022 /PRNewswire/ -- LVW Advisors , a Rochester-based independent financial advisory firm, is thrilled to announce that CEO and Founder Lori Van Dusen has been named CEO of the Year for 2022 by RIA Intel, part of Institutional Investor, a leading international business-to-business publication.
  • This year's awards are the first of their kind from RIA Intel.
  • "I'm incredibly grateful to RIA Intel and Institutional Investor for choosing me for this wonderful recognition," Van Dusen said.
  • And it would never have happened if not for the hard-working advisors and other LVW staff who support me and our clients."

New Hire Announcement- Managing Director- Investment Banking Head of Specialty Finance

Retrieved on: 
Tuesday, June 7, 2022

BOCA RATON, Fla., June 7, 2022 /PRNewswire/ -- Revere Securities is pleased to announce that Robert (Rob) Nathan has joined the firm as Managing Director, Investment Banking Head of Specialty Finance.

Key Points: 
  • BOCA RATON, Fla., June 7, 2022 /PRNewswire/ -- Revere Securities is pleased to announce that Robert (Rob) Nathan has joined the firm as Managing Director, Investment Banking Head of Specialty Finance.
  • Most recently, Mr. Nathan was a managing director of investment banking at Primary Capital, LLC.
  • His Investment Banking experience and extensive relationships will significantly enhance Revere Securities' Investment Banking and Capital Markets team."
  • The firm has industry focused sales specialists who possess "buy-side" experience; therefore, providing a sound, alternate perspective, to the investment process.

Snowden Lane Partners Builds On 2022 Momentum, Adds New Advisor Team

Retrieved on: 
Tuesday, May 31, 2022

Based in Snowden Lanes New York City headquarters, The Conway Group is the third team to join the firm in recent weeks.

Key Points: 
  • Based in Snowden Lanes New York City headquarters, The Conway Group is the third team to join the firm in recent weeks.
  • He joins Snowden Lane as a Senior Partner and Managing Director alongside Daysi Leiva, who will serve as a Senior Registered Client Relationship Manager with The Conway Group.
  • We are excited to welcome Tom and Daysi to Snowden Lane, as both have earned tremendous reputations in our industry, said Lyle LaMothe, Chairman of Snowden Lane Partners.
  • Snowden Lane is a nationally branded, open-architecture, hybrid registered investment advisor and broker-dealer that provides wealth advisory services to high net-worth individuals, families, and institutional clients.